There is increasing evidence that the clinical and pathogenetic

Size: px
Start display at page:

Download "There is increasing evidence that the clinical and pathogenetic"

Transcription

1 Retinal Microvascular Changes and Risk of Stroke The Singapore Malay Eye Study Carol Yim-lui Cheung, PhD; Wan Ting Tay, MAppStat; M. Kamran Ikram, MD, PhD; Yi Ting Ong, BSc; Deidre A. De Silva, MRCP; Khuan Yew Chow, MBBCh; Tien Yin Wong, MD, PhD Background and Purpose To examine the relationship between retinal microvascular measures and incident stroke in an Asian Malay population. Methods We conducted a prospective, population-based cohort study of Asian Malay persons 40 to 80 years at baseline. Retinal microvascular signs were assessed from baseline retinal photographs including quantitative retinal microvascular parameters (caliber, branching angle, tortuosity, and fractal dimension) and qualitative retinopathy signs. Incident stroke cases were identified during the follow-up period. Cox proportional-hazards regression and incremental usefulness analysis (calibration, discrimination, and reclassification) were performed. Results A total of 3189 participants were free of prevalent stroke at baseline. During the follow-up (median, 4.41 years), 51 (1.93%) participants had an incident stroke event. In Cox proportional-hazards models adjusting for established stroke predictors (age, sex, systolic blood pressure, total cholesterol, low-density lipoprotein cholesterol, smoking, glycosylated hemoglobin, and antihypertensive medication), retinopathy (hazard ratio, 1.94; 95% confidence interval, ) and larger retinal venular caliber (hazard ratio, 3.28; 95% confidence interval, , comparing fourth versus first quartiles) were associated with risk of stroke. Compared with the model with only established risk factors, the addition of retinal measures improved the prediction of stroke (C-Statistic versus 0.792; P=0.017) and correctly reclassified 5.9% of participants with incident stroke and 3.4% of participants with no incident stroke. Conclusions Retinal microvascular changes are related to an increased risk of stroke in Asian Malay, consistent with data from white populations. Retinal imaging improves the discrimination and stratification of stroke risk beyond that of established risk factors by a significant but small margin. (Stroke. 2013;44: ) Key Words: Asian Continental Ancestry Group epidemiology retinal vascular imaging stroke There is increasing evidence that the clinical and pathogenetic pattern, and risk factor profile, of stroke varies among different ethnic groups. 1 Asians, for example, have a high prevalence of intracranial large artery disease and cerebral small vessel disease and a stronger relationship between blood pressure and stroke risk. 2,3 Investigating any race-ethnic disparity may improve understanding of stroke pathogenesis, and thus, the design of specific stroke prevention programs in different populations. The retinal blood vessels, measuring 100 to 300 µm in size, offer a unique and easily accessible window to study correlates and consequences of cerebral microvascular disease, because the retina and brain share similar anatomic features and physiological properties. 4 In the last decade, there have been several population-based and clinical studies in white populations which have consistently shown that retinal microvascular signs (eg, retinopathy and retinal venular widening), assessed from retinal photographs, are predictors of clinical stroke events, 5 9 stroke death and are associated with subclinical measures of cerebral disease However, there exist 2 major gaps in the current literature. First, there have been no prior studies examining these relationships in Asian populations. Second, although most studies have examined the role of the caliber (diameter) of the retinal vessels in stroke, a range of newer retinal microvascular features, such as retinal fractal dimension and tortuosity, which reflect the branching network and complexity of retinal vasculature, have recently been linked to stroke However, few studies have prospectively examined the relationship of these new retinal associations with stroke, and importantly, whether there is incremental benefit of a retinal photographic assessment, in terms of discrimination, Received April 8, 2013; final revision received May 27, 2013; accepted May 29, From the Singapore Eye Research Institute, Singapore National Eye Centre, Singapore (C.Y.C., W.T.T., M.K.I., Y.T.O., T.Y.W.); Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore (C.Y.C., M.K.I., Y.T.O., T.Y.W.); Centre for Quantitative Medicine, Duke-NUS Graduate Medical School, Singapore (C.Y.C.); Memory Aging and Cognition Centre, National University Health System, Singapore (M.K.I.); Department of Neurology, Singapore General Hospital Campus, National Neuroscience Institute, Singapore (D.A.D.S.); and National Registry of Diseases Office, Singapore (K.Y.C.). The online-only Data Supplement is available with this article at /-/DC1. Correspondence to Carol Y. Cheung, PhD, Singapore Eye Research Institute, Singapore National Eye Centre, 11 Third Hospital Ave, Singapore carol.cheung.y.l@seri.com.sg 2013 American Heart Association, Inc. Stroke is available at DOI: /STROKEAHA

2 Cheung et al Retinal Microvascular Changes and Risk of Stroke 2403 calibration, and reclassification in stroke risk beyond established risk factors, is unknown. 21 In this study, we examined prospectively the association of a comprehensive range of retinal microvascular abnormalities, including new microvascular parameters, and risk of stroke in an Asian population. We also assessed the incremental usefulness of adding retinal photographic measures to established risk factors for stroke prediction. Methods Study Population Data for this analysis were derived from the Singapore Malay Eye study (SiMES), a population-based study of eye diseases in urban Malay adults ranging in age between 40 and 80 years residing in Southwestern Singapore. In brief, subjects were selected using an age-stratified (by 10-year age group) random sampling method, from a computer-generated list provided by the Singapore Ministry of Home Affairs. Of 4168 eligible participants, 3280 (78.7%) participated in the study, performed from August 2004 through June The methodology and objectives of the study population are reported in detail elsewhere. 22 Written informed consent was obtained from each participant; the study performed adhered to the Declaration of Helsinki. Ethical approval was obtained from the Singapore Eye Research Institute Institutional Review Board. Participants underwent a standardized interview, systemic and ocular examination, and laboratory investigations at baseline. Retinal Microvascular Assessment Retinal Photography Digital fundus photography was taken using a 45º digital retinal camera (Canon CR-DGi with a 10D SLR digital camera back, Canon, Japan) after pupil dilation using tropicamide 1% and phenylephrine hydrochloride 2.5%. Two retinal images of each eye were obtained, one centered at the optic disc and the other centered at the fovea. The spatial resolution of each image was 3072 by 2048 pixels and the images were stored without compression before analysis. Quantitative Measurements of Retinal Microvasculature We used a semiautomated computer-assisted program (Singapore I Vessel Assessment [SIVA], version 1.0) to measure the retinal microvascular parameters quantitatively from digital retinal photographs. Figure 1 shows a screenshot of retinal microvasculature analyses using the SIVA program. Trained graders, masked to participant characteristics, executed the SIVA program to measure the retinal microvasculature. SIVA automatically identifies the optic disc, places a grid with reference to the center of optic disc, identifies vessel type, and calculates the retinal microvascular parameters. Graders are responsible for the visual evaluation of SIVA-automated measurement and manual intervention if necessary, following a standardized grading protocol. All visible vessels coursing through the specified zone were measured. The intra- and intergrader reliability was assessed and reported previously. 23 A series of retinal microvascular parameters were measured and outputted automatically to quantify the retinal vasculature comprehensively using the SIVA program including caliber, tortuosity, bifurcation, and fractal (Appendix in the online-only Data Supplement). The details of the retinal microvascular parameters are reported elsewhere Qualitative Assessment of Retinopathy Lesions The digital retinal photographs were analyzed for qualitative changes by trained graders based on a standardized protocol and compared with a standard set of images. Retinopathy signs (microaneuryms, hemorrhages, or exudates) were assessed. 23 Retinopathy was defined as being present if the retinopathy score (a scale modified from the Airlie House classification system) was at level Typical examples of these signs are shown in the Figure in the online-only Data Supplement. Assessment of Stroke Outcome Previous stroke events were ascertained through self-reporting. Incident stroke from all causes that occurred during the period between baseline examination and December 31, 2009, was obtained by linking with the stroke cases registered by National Registry of Diseases Office, Singapore, by record linkage. Because the Register is electronically captured and is compulsory by law, and because of a unique identifier number for all Singapore citizens and residents (National Registration Identity Card), the Registry is expected to capture virtually all stroke cases. New stroke cases are identified by the Registry through various sources including notifications by healthcare professionals, hospital data for cases admitted to hospitals, and pathology and laboratory reports. The Registry manages the database with quality assurance to ensure that all data collected for the registries have been validated and are properly anonymized before analysis. 27,28 Assessment of Established Risk Factors and C-reactive protein The established risk factors (age, sex, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, glycosylated hemoglobin, body mass index, smoking, and use of antihypertensive medication) and C-reactive protein were assessed under standardized conditions. Systolic and diastolic blood pressures were measured using a digital automatic blood pressure monitor (Dinamap model Pro Series DP110X-RW, 100V2, GE Medical Systems Information Technologies Inc, Milwaukee, WI), after the subject was seated for at least 5 minutes. Blood pressure was measured twice, 5 minutes later. A third measurement was made if the systolic blood pressure differed by >10 mm Hg or the diastolic by >5 mm Hg. The mean between the 2 closest readings was then taken as the blood pressure of that individual. Hypertension was defined as systolic blood pressure of 140 mm Hg, diastolic blood pressure of 90 mm Hg, a self-reported history of physician-diagnosed hypertension or use of antihypertensive medication. Nonfasting venous blood samples were analyzed at the National University Hospital Reference Laboratory for biochemical testing of serum total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, glycosylated hemoglobin, creatinine, and glucose. Diabetes mellitus was identified if the random plasma glucose was 11.1 mmol/l, participants self-reported use of diabetic medication, or had physician-diagnosed diabetes mellitus. Current smokers were defined as those currently smoking any number of cigarettes (ie, current versus past/never). Alcohol consumption was defined as those currently drinking alcoholic beverages daily or on some days (ie, current versus past/never). Body mass index was calculated as body weight (in kilograms) divided by body height (in meters squared). Serum high-sensitivity C-reactive protein (hscrp) was measured in frozen plasma that had been stored at 80 C at the National University Hospital Reference laboratory using an immuno-turbidimetric assay (Intra-assay precision %; Interassay precision %) implemented on a Roche Integra 400 (Roche Diagnostics, Rotkreuz, Switzerland). The detection limit of this assay is 0.07 mg/l and the coefficient variation is 2.9% at 6.3 mg/l and 3.9% at 108 mg/l mean value. Statistical Analysis Independent t test or χ 2 tests were used to examine the differences in baseline characteristics between included and excluded subjects in SiMES. Cox proportional-hazards regression was used to examine the relation of selected individual retinal microvascular parameters measured by SIVA and retinopathy signs to the risk of stroke, adjusting for age-sex and established risk factors (age, sex, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, glycosylated hemoglobin, body mass index, smoking, and use of antihypertensive medication) at baseline.

3 2404 Stroke September 2013 Figure 1. Retinal fundus photograph assessed quantitatively by the Singapore I Vessel Assessment (SIVA) software with superimposed modified Atherosclerosis Risk in Communities study (ARIC) grid and vessel tracing (arterioles are in red and venules are in blue). The modified ARIC grid is composed of 4 concentric circles which demarcate an average optic disc, zone B defined as the region from halfdisc diameter to 1-disc diameter from the disc, and zone C defined as the region from half-disc diameter to 2-disc diameter from the disc. Next, we examined the incremental usefulness of adding retinal measures for stroke prediction. First, we only added the significant predictors from Cox proportional-hazards regression models. Second, we added all the outputted SIVA retinal vascular parameters and retinopathy signs in this analysis because these will all be included in the retinal assessment when extending the screening of retinal abnormalities in routine clinical practice in the next phase. We used principal component analysis to summarize the SIVA data to minimize loss of information. We retained the first to 12th unrotated components which explained 85% of the total variance in the principle component analysis. We calculated Harrell C-Statistic for the Cox regression models to quantify the predictive discrimination. We performed 5 models to examine the predictive discrimination. Model 1 included the established risk factors, model 2 included established risk factors+hscrp, model 3 included retinal venular caliber and presence of retinopathy (the significant predictors from Cox proportional-hazards regression analysis) and established risk factors, model 4 included all retinal measures and established risk factors, and model 5 includes all retinal measures, established risk factors and hscrp. Differences in C-Statistic after the addition of retinal measures and hscrp to a model with established risk factors were estimated and compared. We graphically assessed the calibration of risk prediction by comparing the predicted frequency of stroke events with the observed frequency. We calculated Hosmer Lemeshow χ 2 statistic for the models to test goodness-of-fit. 29 P<0.05 represents a significant difference between the expected and observed event rates, indicating that the model is not well-calibrated. Finally, we examined the net reclassification improvement in stroke risk prediction when adding retinal measures. We first generated predicted probabilities for the incident stroke outcome using established risk factors only, and classified the subjects into low- (0% to 2%), intermediate (2% to 5%), and high-risk (>5%) categories. 8 We then generated predicted probability for the incident stroke outcome again using both retinal measures and established risk factors. We used the same cut-off points and the subjects were reassigned to low-, intermediate, or high-risk categories. In supplementary analyses, we used the factors from Framingham Risk score (age, sex, total cholesterol, high-density lipoprotein cholesterol, smoking, diabetes mellitus, systolic blood pressure, and use of antihypertensive medication) to further examine the incremental benefit of retinal measures. We regarded P values of <0.05 from 2-sided tests to indicate statistical significance. All statistical analyses were performed using STATA version 12. Results The baseline characteristics of the SiMES population are shown in the Table in the online-only Data Supplement. We excluded the subjects with prevalent stroke (n=82), none or ungradable retinal images (n=348), and individuals with missing data (n=206). A total of 2644 participants (80.6% of SiMES) were included in the final analysis. Excluded participants were older, and had higher levels of blood pressure, serum creatinine, glucose, and glycosylated hemoglobin, comparing with the included subjects. During the follow-up period (median, 4.41 years; range, years), 51 participants developed stroke in SiMES. Of these incident stroke cases, 82% were ischemic. Cox Regression The hazard ratios of selected retinal vascular parameters and retinopathy signs associated with stroke risk are shown in Table 1. In Cox proportional-hazards models adjusting for established risk factors, wider central retinal vein equivalent (hazard ratio [HR], 3.28; 95% confidence interval, , comparing fourth versus first quartiles) and presence of retinopathy (HR, 1.94; 95% confidence interval, ) were associated with risk of stroke. Straighter retinal arteriole (HR,

4 Cheung et al Retinal Microvascular Changes and Risk of Stroke 2405 Table 1. Relation of Selected Major Retinal Vascular Parameters and Retinopathy Signs to Risk of Stroke Age-Sex Adjusted Hazard Ratio (95% CI) P Value Multivariable* Adjusted Hazard Ratio (95% CI) Central retinal artery equivalent First quartile 1.25 ( ) ( ) Second quartile 1.11 ( ) ( ) Third quartile 1.15 ( ) ( ) Fourth quartile Referent Referent Per SD decrease 1.20 ( ) ( ) Central retinal vein equivalent Second quartile 2.84 ( ) ( ) Third quartile 2.24 ( ) ( ) Fourth quartile 3.96 ( ) ( ) Per SD increase 1.36 ( ) ( ) Retinal arteriolar tortuosity Second quartile 0.37 ( ) ( ) Third quartile 0.95 ( ) ( ) Fourth quartile 0.63 ( ) ( ) Per SD increase 0.86 ( ) ( ) Retinal venular tortuosity Second quartile 0.92 ( ) ( ) Third quartile 1.52 ( ) ( ) Fourth quartile 1.26 ( ) ( ) Per SD increase 1.01 ( ) ( ) Retinal arteriolar branching angle Second quartile 1.15 ( ) ( ) Third quartile 0.86 ( ) ( ) Fourth quartile 1.10 ( ) ( ) Per SD increase 1.00 ( ) ( ) Retinal venular branching angle Second quartile 0.53 ( ) ( ) Third quartile 0.57 ( ) ( ) Fourth quartile 0.92 ( ) ( ) Per SD increase 0.96 ( ) ( ) Retinal vascular fractal dimension Second quartile 0.77 ( ) ( ) Third quartile 1.41 ( ) ( ) Fourth quartile 1.17 ( ) ( ) Per SD increase 1.02 ( ) ( ) Presence of retinopathy 2.90 ( ) < ( ) CI indicates confidence interval; HbA1c, glycosylated hemoglobin; and HDL, high-density lipoprotein. *Adjusted for age, sex, systolic blood pressure, total cholesterol, HDL cholesterol, smoking, HbA1c, and antihypertensive medication P Value 0.38; 95% CI, , comparing second versus first quartiles) was also associated with risk of stroke, but the association was not significant when retinal arteriolar tortuosity was analyzed as continuous variable. Other retinal vascular parameters were not associated with risk of stroke. With the given sample size, we had a statistical power of 80% with a P value of 0.05 significance level to detect a HR of 1.5 with each SD increase in retinal vascular parameters and presence of retinopathy. Discrimination Table 2 shows C-Statistic for Cox regression models predicting stroke in the whole sample. The C-Statistic for discrimination of

5 2406 Stroke September 2013 Table 2. Stroke C-Statistic for Cox Regression Models Predicting Whole Sample C-Statistic for Stroke P Value* Model 1: established risk factors Referent Model 2: established risk factors+hscrp Model 3: established risk factors+retinal venular caliber and presence of retinopathy Model 4: established risk factors+all retinal measures Model 5: established risk factors+all retinal measures and hscrp Established risk factors include age, sex, systolic blood pressure, total cholesterol, HDL cholesterol, HbA1c, body mass index, smoking, and use of antihypertensive medication at baseline. HDL indicates high-density lipoprotein; HbA1c, glycosylated hemoglobin; and hscrp, high-sensitivity C-reactive protein. *P values are for the comparison with the model with established risk factors. stroke prediction increased from to after all retinal measures are added in the models with established risk factors (Model 4). The difference in the C-Statistic was statistically significant (P=0.017). Adding retinal venular caliber and presence of retinopathy (Model 3) and hscrp (Models 2 and 5) did not improve the discrimination of stroke prediction significantly. Calibration Figure 2 shows the calibration assessment by dividing the population at risk into deciles of predicted risk versus the observed event rate. The Hosmer-Lemeshow χ 2 statistics was 5.31 (P=0.72) for the model with established risk factors and was 3.43 (P=0.90) with the addition of retinal measures (Model 4), indicating that neither model had a significant lack of fit. Reclassification Table 3 shows the reclassification of stroke risk after addition of retinal measures in the prediction models. Among the subjects with incident stroke event, 6 subjects (11.8%) were reclassified to a higher risk category and 3 subjects (5.9%) were reclassified to a lower risk category. Among the subjects without incident stroke event, 285 subjects (11.0%) were reclassified to a lower risk category and 198 subjects (7.6%) were reclassified to a higher risk category. The overall net reclassification improvement was 9.3% (P<0.001), indicating a significantly greater number were being reclassified appropriately than were being reclassified inappropriately. We repeated the analyses of discrimination and reclassification by using the factors from Framingham Risk score. The addition of retinal measures consistently improved discrimination and risk stratification for stroke in the models with Framingham Risk score. Discussion In this study, we demonstrated that retinal microvascular signs (retinopathy signs and larger retinal venular caliber), were associated with an increased risk of stroke in this Asian Malay population, consistent with studies in white populations. 8,30 Furthermore, we showed that the addition of retinal measures significantly improves discrimination and risk stratification for stroke when compared with the models on established risk factors and hscrp, although the absolute improvement in prediction was modest. It has long been known that established or traditional risk factors do not fully predict stroke risk, accounting for only 60% of the attributable risk. 31 Thus, there is value in examining additional biomarkers which may further improve stroke prediction. Microvascular processes which cause ischemia are important contributors to the brain diseases. Pathological studies have shown a close correlation between cerebral and retinal vascular findings. 32 With advance in retinal photography, retinal vascular imaging has been proposed to be a noninvasive tool to assess the cerebral microvasculature objectively and reliably for better understanding of the pathophysiological processes involved in cerebral small vessel disease. 4,33 To our best knowledge, this is the first study to examine the relationship between retinal microvascular abnormalities and the risk of stroke in an Asian population. Our finding adds to existing data, largely in white populations, which convincingly show links between retinal vascular changes (retinopathy signs and retinal venular widening) and clinical 5 9,34 and Figure 2. Calibration plots for the predictive models with (A) established risk factors and (B) established risk factors+retinal measures, by dividing the population at risk into deciles of predicted stroke risk vs the observed stroke event rate. The Hosmer-Lemeshow χ 2 is used to test the goodness-of-fit.

6 Cheung et al Retinal Microvascular Changes and Risk of Stroke 2407 Table 3. Five-Year Risk of Stroke Predicted by Models With and Without Retinal Measures, Singapore Malay Eye Study, 2004 to 2011 Retinal+Established Risk Category Reclassification Net Correct Low Intermediate High Total Higher Risk Lower Risk Reclassification, % Subjects with incident stroke event Established risk category Low Intermediate High Total Subjects with no incident stroke event Established risk category Low Intermediate High Total Net reclassification improvement, % 9.3 (P<0.001) Established risk factors include age, sex, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, glycosylated hemoglobin, body mass index, smoking, and use of antihypertensive medication at baseline. subclinical stroke, providing strong evidence that these 2 specific retinal microvascular changes are associated with stroke and the role of microvascular pathology in stroke development is also important in Malays. In addition to retinopathy signs and retinal vascular caliber, we have also explored a range of new retinal vascular parameters, quantifying the geometric branching network (fractals, tortuosity, and bifurcation) of retinal vasculature, with risk of stroke in this study. These new retinal parameters may reflect the optimality and efficiency of blood distribution in the microvasculature, 35,36 and have been recently linked to stroke However, there are limited prospective data on stroke and the results are inconsistent. Witt 37 has reported that retinal vascular tortuosity and bifurcation are not associated with stroke mortality in a nested case-control study in a white population. In another prospective study, Kawasaki 20 has showed that low spectrum fractal dimension is associated with 2-fold higher risk of incident stroke event or stroke-related mortality in a nested case-control study in a white population. We found that straighter retinal arteriole was marginally associated with risk of stroke; however, the association was not significant when retinal arteriolar tortuosity was analyzed as continuous variable, and we did not find any significant associations between retinal vascular fractal dimension and branching angle with stroke risk in this Asian cohort. The reason for the discrepancies may be related to smaller sample size that limited the power of our study to detect association with smaller effect sizes (HR<1.5). Alternatively, this may be related to ethnic differences (Asian Malays versus white), suggesting that microvascular pathology, as reflected by retinal vascular fractal dimension, may not play an equally important role in different ethnicities. In terms of clinical prediction, there seems to be incremental value of adding all these new retinal vascular parameters, in addition to retinopathy signs and retinal venular caliber, for stroke prediction. We showed that addition of all retinal measures improves discrimination and reclassification for stroke, when compared with the models using only established risk factors. In addition, we did not observe any improvement for discrimination of stroke prediction when hscrp was added in the models, consistent with reports that its discriminative value may be limited Our data suggest that the addition of retinal measures, which provides surrogate information on microvascular processes in cerebral vasculature, can improve risk stratification in identifying patients who are at high risk of stroke more accurately. However, further work is needed to optimize the risk-prediction algorithm, to determine how it may influence in clinical decision making, to identify the most appropriate subgroup of patients, and to estimate the costeffectiveness and acceptability to patients in different settings. Strengths of this study include a prospective design, a study population drawn from the community, standardized retinal measures from photographs, validated ascertainment of incident stroke cases, and detailed information on a variety of potential confounders. Potential limitations should also be mentioned. First, we do not have data on left ventricular hypertrophy and atrial fibrillation for SiMES which are factors for Framingham stroke risk score. Despite such limitation, the models still had generally good discrimination (via the C-Statistic) and calibration. Second, ischemic stroke are more common in Singapore. 28 In this prospective cohort, 82% incident stroke cases were ischemic stroke. We did not have adequate power to perform stratified analysis by stroke subtypes. Third, only ethnic Malays were examined in this study and the findings may vary in other ethnic groups. In summary, our population-based study in an Asian Malay cohort confirms previous findings in white populations that specific retinal microvascular signs (retinopathy and retinal venular widening) are associated with stroke risk. We further showed that the addition of retinal assessment significantly improves stroke risk discrimination and stratification beyond established risk factors and hscrp, although the absolute improvement in risk prediction, and thus, the clinical

7 2408 Stroke September 2013 significance of retinal vascular imaging for stroke risk stratification, requires further evaluation. Sources of Funding This work was supported by National Medical Research Council, Singapore (R607/28/2008, CSA/038/2013). Disclosure Dr Wong is advisory board member and consultant to Abbott, Novartis, Pfizer, Allergan, and Bayer. The other authors have no conflicts to report. References 1. Sacco RL, Boden-Albala B, Abel G, Lin IF, Elkind M, Hauser WA, et al. Race-ethnic disparities in the impact of stroke risk factors: the Northern Manhattan Stroke study. Stroke. 2001;32: Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 1998; 352: Wong LK. Global burden of intracranial atherosclerosis. Int J Stroke. 2006;1: Wong TY. Is retinal photography useful in the measurement of stroke risk? Lancet Neurol. 2004;3: Mitchell P, Wang JJ, Wong TY, Smith W, Klein R, Leeder SR. Retinal microvascular signs and risk of stroke and stroke mortality. Neurology. 2005;65: Ikram MK, de Jong FJ, Bos MJ, Vingerling JR, Hofman A, Koudstaal PJ, et al. Retinal vessel diameters and risk of stroke: the Rotterdam Study. Neurology. 2006;66: Yatsuya H, Folsom AR, Wong TY, Klein R, Klein BE, Sharrett AR; ARIC Study Investigators. Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis Risk in Communities Study. Stroke. 2010;41: McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE, et al. Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol. 2009;170: Wieberdink RG, Ikram MK, Koudstaal PJ, Hofman A, Vingerling JR, Breteler MM. Retinal vascular calibers and the risk of intracerebral hemorrhage and cerebral infarction: the Rotterdam Study. Stroke. 2010;41: Wong TY, Klein R, Klein BE, Tielsch JM, Hubbard L, Nieto FJ. Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol. 2001;46: Wong TY, Klein R, Nieto FJ, Klein BE, Sharrett AR, Meuer SM, et al. Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology. 2003;110: Wang JJ, Liew G, Klein R, Rochtchina E, Knudtson MD, Klein BE, et al. Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations. Eur Heart J. 2007;28: Sairenchi T, Iso H, Yamagishi K, Irie F, Okubo Y, Gunji J, et al. Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study. Circulation. 2011;124: Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, et al; ARIC Investigators. Atheroslerosis Risk in Communities Study. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA. 2002;288: Cooper LS, Wong TY, Klein R, Sharrett AR, Bryan RN, Hubbard LD, et al. Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke. 2006;37: Kawasaki R, Cheung N, Mosley T, Islam AF, Sharrett AR, Klein R, et al. Retinal microvascular signs and 10-year risk of cerebral atrophy: the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2010;41: Cheung N, Mosley T, Islam A, Kawasaki R, Sharrett AR, Klein R, et al. Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study. Brain. 2010;133 (Pt 7): Cheung N, Liew G, Lindley RI, Liu EY, Wang JJ, Hand P, et al; Multi- Center Retina & Stroke Study Collaborative Group. Retinal fractals and acute lacunar stroke. Ann Neurol. 2010;68: Doubal FN, MacGillivray TJ, Patton N, Dhillon B, Dennis MS, Wardlaw JM. Fractal analysis of retinal vessels suggests that a distinct vasculopathy causes lacunar stroke. Neurology. 2010;74: Kawasaki R, Che Azemin MZ, Kumar DK, Tan AG, Liew G, Wong TY, et al. Fractal dimension of the retinal vasculature and risk of stroke: a nested case-control study. Neurology. 2011;76: Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, et al; American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119: Foong AW, Saw SM, Loo JL, Shen S, Loon SC, Rosman M, et al. Rationale and methodology for a population-based study of eye diseases in Malay people: the Singapore Malay Eye Study (SiMES). Ophthalmic Epidemiol. 2007;14: Cheung CY, Tay WT, Mitchell P, Wang JJ, Hsu W, Lee ML, et al. Quantitative and qualitative retinal microvascular characteristics and blood pressure. J Hypertens. 2011;29: Cheung CY, Hsu W, Lee ML, Wang JJ, Mitchell P, Lau QP, et al. A new method to measure peripheral retinal vascular caliber over an extended area. Microcirculation. 2010;17: Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology. 1999;106: Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008;115: National Registry of Diseases Office Singapore. Accessed November 2, Ministry of Health Singapore. Trends in stroke in Singapore stroke%20(inp-12 4)_final.pdf. Accessed November 2, May S, Hosmer DW. A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model. Lifetime Data Anal. 1998;4: Doubal FN, Hokke PE, Wardlaw JM. Retinal microvascular abnormalities and stroke: a systematic review. J Neurol Neurosurg Psychiatry. 2009;80: Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371: Goto I, Katsuki S, Ikui H, Kimoto K, Mimatsu T. Pathological studies on the intracerebral and retinal arteries in cerebrovascular and noncerebrovascular diseases. Stroke. 1975;6: Wong TY, Klein R, Klein BE, Tielsch JM, Hubbard L, Nieto FJ. Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol. 2001;46: Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, Hubbard LD, et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet. 2001;358: Murray CD. The physiological principle of minimum work: I. the vascular system and the cost of blood volume. Proc Natl Acad Sci USA. 1926;12: Sherman TF. On connecting large vessels to small. The meaning of Murray s law. J Gen Physiol. 1981;78: Witt N, Wong TY, Hughes AD, Chaturvedi N, Klein BE, Evans R, et al. Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke. Hypertension. 2006;47: Elkind MS, Leon V, Moon YP, Paik MC, Sacco RL. High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction. Stroke. 2009;40: Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med. 2006;145: Lloyd-Jones DM, Liu K, Tian L, Greenland P. Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med. 2006;145:35 42.

Prognostic impact of uric acid in patients with stable coronary artery disease

Prognostic impact of uric acid in patients with stable coronary artery disease Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

Mortality Assessment Technology: A New Tool for Life Insurance Underwriting

Mortality Assessment Technology: A New Tool for Life Insurance Underwriting Mortality Assessment Technology: A New Tool for Life Insurance Underwriting Guizhou Hu, MD, PhD BioSignia, Inc, Durham, North Carolina Abstract The ability to more accurately predict chronic disease morbidity

More information

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,

More information

Atherosclerosis of the aorta. Artur Evangelista

Atherosclerosis of the aorta. Artur Evangelista Atherosclerosis of the aorta Artur Evangelista Atherosclerosis of the aorta Diagnosis Classification Prevalence Risk factors Marker of generalized atherosclerosis Risk of embolism Therapy Diagnosis Atherosclerosis

More information

C-Reactive Protein and Diabetes: proving a negative, for a change?

C-Reactive Protein and Diabetes: proving a negative, for a change? C-Reactive Protein and Diabetes: proving a negative, for a change? Eric Brunner PhD FFPH Reader in Epidemiology and Public Health MRC Centre for Causal Analyses in Translational Epidemiology 2 March 2009

More information

Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults. Learn and Live SM. ACCF/AHA Pocket Guideline

Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults. Learn and Live SM. ACCF/AHA Pocket Guideline Learn and Live SM ACCF/AHA Pocket Guideline Based on the 2010 ACCF/AHA Guideline Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults November 2010 Guideline for Assessment of Cardiovascular

More information

Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study

Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study European Journal of Clinical Investigation (2007) 37, 925 932 DOI: 10.1111/j.1365-2362.2007.01888.x Blackwell Publishing Ltd Review Assessing risk of myocardial infarction and stroke: new data from the

More information

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES Niteesh K. Choudhry, MD, PhD Harvard Medical School Division of Pharmacoepidemiology and Pharmacoeconomics

More information

Alcohol Intake and Cerebral Abnormalities on Magnetic Resonance Imaging in a Community-Based Population of Middle-Aged Adults

Alcohol Intake and Cerebral Abnormalities on Magnetic Resonance Imaging in a Community-Based Population of Middle-Aged Adults Alcohol Intake and Cerebral Abnormalities on Magnetic Resonance Imaging in a Community-Based Population of Middle-Aged Adults The Atherosclerosis Risk in Communities (ARIC) Study Jingzhong Ding, PhD; Marsha

More information

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological

More information

African Americans & Cardiovascular Diseases

African Americans & Cardiovascular Diseases Statistical Fact Sheet 2013 Update African Americans & Cardiovascular Diseases Cardiovascular Disease (CVD) (ICD/10 codes I00-I99, Q20-Q28) (ICD/9 codes 390-459, 745-747) Among non-hispanic blacks age

More information

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine Disclosures & Relevant Relationships I have nothing to disclose No financial conflicts Editor,

More information

The International Agenda for Stroke

The International Agenda for Stroke 1st Global Conference on Healthy Lifestyles and Noncommunicable Diseases Control Moscow, 28-29 April, 2011 The International Agenda for Stroke Marc Fisher MD, University of Massachusetts Editor-in-Chief,

More information

Statins and Risk for Diabetes Mellitus. Background

Statins and Risk for Diabetes Mellitus. Background Statins and Risk for Diabetes Mellitus Kevin C. Maki, PhD, FNLA Midwest Center for Metabolic & Cardiovascular Research and DePaul University, Chicago, IL 1 Background In 2012 the US Food and Drug Administration

More information

How To Know If You Have Microalbuminuria

How To Know If You Have Microalbuminuria 3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate

More information

Malmö Preventive Project. Cardiovascular Endpoints

Malmö Preventive Project. Cardiovascular Endpoints Malmö Preventive Project Department of Clinical Sciences Malmö University Hospital Lund University Malmö Preventive Project Cardiovascular Endpoints End of follow-up: 31 Dec 2008 * Report: 21 June 2010

More information

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Scottish Diabetes Survey 2014. Scottish Diabetes Survey Monitoring Group

Scottish Diabetes Survey 2014. Scottish Diabetes Survey Monitoring Group Scottish Diabetes Survey 2014 Scottish Diabetes Survey Monitoring Group Contents Table of Contents Contents... 2 Foreword... 4 Executive Summary... 6 Prevalence... 8 Undiagnosed diabetes... 21 Duration

More information

THE RISK DISTRIBUTION CURVE AND ITS DERIVATIVES. Ralph Stern Cardiovascular Medicine University of Michigan Ann Arbor, Michigan. stern@umich.

THE RISK DISTRIBUTION CURVE AND ITS DERIVATIVES. Ralph Stern Cardiovascular Medicine University of Michigan Ann Arbor, Michigan. stern@umich. THE RISK DISTRIBUTION CURVE AND ITS DERIVATIVES Ralph Stern Cardiovascular Medicine University of Michigan Ann Arbor, Michigan stern@umich.edu ABSTRACT Risk stratification is most directly and informatively

More information

Guidelines for the management of hypertension in patients with diabetes mellitus

Guidelines for the management of hypertension in patients with diabetes mellitus Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes

More information

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING

More information

Appendix: Description of the DIETRON model

Appendix: Description of the DIETRON model Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough

More information

ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE

ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE I- BACKGROUND: Coronary artery disease and stoke are the major killers in the United States.

More information

Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment

Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment What does that mean for you? Your healthcare provider has determined that you may be at risk for cardiovascular disease (CVD).

More information

STROKE April 2011 Dr Amer Jafar A delay in recognizing early warning signs (WS) and risk factors (RF) of ischemic stroke causes a delay in treatment Evaluated: knowledge of RF and WS and the impact of

More information

Diabetes Prevention in Latinos

Diabetes Prevention in Latinos Diabetes Prevention in Latinos Matthew O Brien, MD, MSc Assistant Professor of Medicine and Public Health Northwestern Feinberg School of Medicine Institute for Public Health and Medicine October 17, 2013

More information

Mississippi Delta Health Collaborative Mississippi State Department of Health 1

Mississippi Delta Health Collaborative Mississippi State Department of Health 1 The Impact of Community Health Workers on Cardiovascular Risk Reduction : Findings from the Clinical Community Health Worker Initiative Mississippi Delta Health Collaborative Mississippi State Department

More information

General and Abdominal Adiposity and Risk of Death in Europe

General and Abdominal Adiposity and Risk of Death in Europe Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke General and Abdominal Adiposity and Risk of Death in Europe Tobias Pischon Department of Epidemiology German Institute of Human Nutrition Potsdam-Rehbruecke

More information

The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT?

The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT? AACE 23 rd Annual Scientific and Clinical Congress (2014) Syllabus Materials: The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT? JoAnn E. Manson, MD, DrPH, FACP, FACE Chief, Division

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY Measure #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS F INDIVIDUAL MEASURES:

More information

Prevalence of Diabetic Retinopathy: A Pilot Study from the SEARCH for Diabetes in Youth Study

Prevalence of Diabetic Retinopathy: A Pilot Study from the SEARCH for Diabetes in Youth Study Prevalence of Diabetic Retinopathy: A Pilot Study from the SEARCH for Diabetes in Youth Study Elizabeth J Mayer-Davis, PhD University of North Carolina at Chapel Hill For the SEARCH Study Group, May 2014

More information

Obesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000

Obesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000 P F I Z E R F A C T S Obesity in the United States Workforce Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000 p p Obesity in The United States Workforce One

More information

Achieving Quality and Value in Chronic Care Management

Achieving Quality and Value in Chronic Care Management The Burden of Chronic Disease One of the greatest burdens on the US healthcare system is the rapidly growing rate of chronic disease. These statistics illustrate the scope of the problem: Nearly half of

More information

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

MY TYPE 2 DIABETES NUMBERS

MY TYPE 2 DIABETES NUMBERS BLOOD SUGAR MANAGEMENT GUIDE MY TYPE 2 DIABETES NUMBERS Understanding and Tracking the ABCs of Type 2 Diabetes 1 BLOOD MY TYPE SUGAR 2 DIABETES MANAGEMENT ABC NUMBERS GUIDE When you have type 2 diabetes,

More information

Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost

Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost Naftali Stern Institute of Endocrinology, Metabolism and Hypertension Tel Aviv -Sourasky Medical Center and Sackler

More information

Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines

Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines Mitchell S.V. Elkind, MD, MS Associate Professor of Neurology Columbia University New York, NY Presenter Disclosure Information Mitchell

More information

SIMILAR TO RACIAL DIFFERences

SIMILAR TO RACIAL DIFFERences ORIGINAL INVESTIGATION Racial Differences in the Impact of Elevated Systolic Blood Pressure on Stroke Risk George Howard, DrPH; Daniel T. Lackland, DrPH; Dawn O. Kleindorfer, MD; Brett M. Kissela, MD;

More information

Cardiovascular Disease Risk Factors

Cardiovascular Disease Risk Factors Cardiovascular Disease Risk Factors Risk factors are traits and life-style habits that increase a person's chances of having coronary artery and vascular disease. Some risk factors cannot be changed or

More information

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering

More information

The Long-term Effects of Laser Photocoagulation Treatment in Patients with Diabetic Retinopathy

The Long-term Effects of Laser Photocoagulation Treatment in Patients with Diabetic Retinopathy The Long-term Effects of Laser Photocoagulation Treatment in Patients with Diabetic Retinopathy The Early Treatment Diabetic Retinopathy Follow-up Study Emily Y. Chew, MD, 1 Frederick L. Ferris III, MD,

More information

Scottish Diabetes Survey

Scottish Diabetes Survey Scottish Diabetes Survey 2011 Scottish Diabetes Survey Monitoring Group Foreword The Scottish Diabetes Survey 2011 data reflects many aspects of the quality of diabetes care across the whole of Scotland.

More information

Beware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD

Beware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD 1 Beware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD Executive Summary: The presence of low urine creatinine at insurance testing is associated with increased

More information

Malmö Preventive Project. Cardiovascular Endpoints

Malmö Preventive Project. Cardiovascular Endpoints Malmö Preventive Project Department of Clinical Sciences Skåne University Hospital, Malmö Lund University Malmö Preventive Project Cardiovascular Endpoints End of follow-up: 30 June 2009 Report: 7 October

More information

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators Shaikha Al Naimi Doctor of Pharmacy Student College of Pharmacy Qatar University

More information

NCD for Lipids Testing

NCD for Lipids Testing Applicable CPT Code(s): NCD for Lipids Testing 80061 Lipid panel 82465 Cholesterol, serum or whole blood, total 83700 Lipoprotein, blood; electrophoretic separation and quantitation 83701 Lipoprotein blood;

More information

Scottish Diabetes Survey 2013. Scottish Diabetes Survey Monitoring Group

Scottish Diabetes Survey 2013. Scottish Diabetes Survey Monitoring Group Scottish Diabetes Survey 2013 Scottish Diabetes Survey Monitoring Group Contents Contents... 2 Foreword... 4 Executive Summary... 6 Prevalence... 8 Undiagnosed diabetes... 18 Duration of Diabetes... 18

More information

Relationship of Hemoglobin A1c to Mortality in Nonsmoking Insurance Applicants

Relationship of Hemoglobin A1c to Mortality in Nonsmoking Insurance Applicants JOURNAL OF INSURANCE MEDICINE Copyright E 2007 Journal of Insurance Medicine J Insur Med 2007;39:174 181 MORTALITY Relationship of Hemoglobin A1c to in Nonsmoking Insurance Applicants Robert L. Stout,

More information

Absolute cardiovascular disease risk assessment

Absolute cardiovascular disease risk assessment Quick reference guide for health professionals Absolute cardiovascular disease risk assessment This quick reference guide is a summary of the key steps involved in assessing absolute cardiovascular risk

More information

Diabetes Complications

Diabetes Complications Managing Diabetes: It s s Not Easy But It s s Worth It Presenter Disclosures W. Lee Ball, Jr., OD, FAAO (1) The following personal financial relationships with commercial interests relevant to this presentation

More information

Sanjeev Kumar 1 and Hemlata Jain 2

Sanjeev Kumar 1 and Hemlata Jain 2 IJFSRS: 5(1), June 2012, pp. 51-58, Life Insurance Serials Publications, Underwriting ISSN: when 0974-858 Insurer is Diabetic: A Fuzzy Approach 51 Sanjeev Kumar 1 and Hemlata Jain 2 1,2 Department of Mathematics,

More information

Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity

Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity Jean-Luc MONIN, MD, PhD Henri Mondor University Hospital Créteil, FRANCE Disclosures : None 77-year-old woman, mild dyspnea

More information

Is the Apparent Cardioprotective Effect of Recent Alcohol Consumption Due to Confounding by Prodromal Symptoms?

Is the Apparent Cardioprotective Effect of Recent Alcohol Consumption Due to Confounding by Prodromal Symptoms? American Journal of Epidemiology Copyright 2000 by The Johns Hopkfns University School of Hygiene and Public Health Allrightsreserved Vol. 151, No. 12 Printed In USA. Is the Apparent Cardioprotective Effect

More information

LIPID PANEL CHOLESTEROL LIPOPROTEIN, ELECTROPHORETIC SEPARATION LIPOPROTEIN, DIRECT MEASUREMENT (HDL) LDL DIRECT TRIGLYCERIDES

LIPID PANEL CHOLESTEROL LIPOPROTEIN, ELECTROPHORETIC SEPARATION LIPOPROTEIN, DIRECT MEASUREMENT (HDL) LDL DIRECT TRIGLYCERIDES Test Code Test Name CPT CHOL Cholesterol, Serum 82465 HDL HDL, (High Density Lipoprotein) 83718 TRIG Triglycerides, Serum 84478 FTRIG Triglycerides (Fluid) 84478 LIPID Lipid Panel 80061 LDL LDL (Low Density

More information

CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal

CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal 1. STUDY TITLE: Longitudinal Assessment of Chronic Health Conditions: The Aging of Childhood Cancer Survivors 2. WORKING GROUP AND INVESTIGATORS:

More information

Atrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital

Atrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital Atrial Fibrillation: A Different Perspective Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital Faculty/Presenter Disclosure Faculty: Dr. Michael Heffernan Relationships with commercial

More information

Guide to Biostatistics

Guide to Biostatistics MedPage Tools Guide to Biostatistics Study Designs Here is a compilation of important epidemiologic and common biostatistical terms used in medical research. You can use it as a reference guide when reading

More information

Cardiovascular Endpoints

Cardiovascular Endpoints The Malmö Diet and Cancer Study Department of Clinical Sciences Malmö University Hospital Lund University The Malmö Diet and Cancer Study CV-cohort Cardiovascular Endpoints End of follow-up: 31 Dec * Report:

More information

Measure of Confidence. Glaucoma Module Premium Edition

Measure of Confidence. Glaucoma Module Premium Edition Measure of Confidence Glaucoma Module Premium Edition The Changing Face of Glaucoma Practice Literature 1 Leske et al., Arch Ophthalmol 1997; 115:1051-1057 2 Doughty et al., Surv Ophthalmol 2000; 44:367-408

More information

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität

More information

Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.

Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Associate Investigator Palo Alto Medical Foundation Research Institute Consulting Assistant

More information

Telemedicine. Telemedicine for Pediatric Retinal Diseases. Why ROP? Why ROP? Why ROP? 6/22/2015. Telemedicine in Pediatric Retinal Practice

Telemedicine. Telemedicine for Pediatric Retinal Diseases. Why ROP? Why ROP? Why ROP? 6/22/2015. Telemedicine in Pediatric Retinal Practice Telemedicine for Pediatric Retinal Diseases Telemedicine Synchronous Examination and diagnosis in real-time Traditional medical specialties 2015 Ophthalmic Photographers' Society Mid-Year Program Cagri

More information

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D. TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type

More information

Study Design and Statistical Analysis

Study Design and Statistical Analysis Study Design and Statistical Analysis Anny H Xiang, PhD Department of Preventive Medicine University of Southern California Outline Designing Clinical Research Studies Statistical Data Analysis Designing

More information

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND: STROKE PREVENTION IN ATRIAL FIBRILLATION TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention

More information

Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE

Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE Clinical practice guidelines serve as an educational reference, and do not supersede the clinical judgment of the treating physician with

More information

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1

More information

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY In order to improve the efficiency of PINNACLE Registry data analytics, a missing data analysis has been conducted on PINNACLE Registry data

More information

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION European Medicines Agency London, 19 July 2007 Doc. Ref. EMEA/CHMP/EWP/311890/2007 COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR

More information

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015 STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015 PROJECT TITLE: Analysis of ECG Exercise Stress Testing and Framingham Risk Score in Chest Pain Patients PRIMARY SUPERVISOR NAME: Dr. Edward Tan DEPARTMENT:

More information

How To Prevent A Cardiovascular Event

How To Prevent A Cardiovascular Event The Challenges and Benefits of Cardiovascular Risk Assessment in Clinical Practice Steven A Grover MD, MPA From the McGill Cardiovascular Health Improvement Program and the Divisions of General Internal

More information

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology The chart below lists the measures (and specialty exclusions) that eligible providers must demonstrate

More information

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA A CASE STUDY EXAMINING RISK FACTORS AND COSTS OF UNCONTROLLED HYPERTENSION ISPOR 2013 WORKSHOP

More information

Health risk assessment: a standardized framework

Health risk assessment: a standardized framework Health risk assessment: a standardized framework February 1, 2011 Thomas R. Frieden, MD, MPH Director, Centers for Disease Control and Prevention Leading causes of death in the U.S. The 5 leading causes

More information

Organizing Your Approach to a Data Analysis

Organizing Your Approach to a Data Analysis Biost/Stat 578 B: Data Analysis Emerson, September 29, 2003 Handout #1 Organizing Your Approach to a Data Analysis The general theme should be to maximize thinking about the data analysis and to minimize

More information

With Big Data Comes Big Responsibility

With Big Data Comes Big Responsibility With Big Data Comes Big Responsibility Using health care data to emulate randomized trials when randomized trials are not available Miguel A. Hernán Departments of Epidemiology and Biostatistics Harvard

More information

A Multi-locus Genetic Risk Score for Abdominal Aortic Aneurysm

A Multi-locus Genetic Risk Score for Abdominal Aortic Aneurysm A Multi-locus Genetic Risk Score for Abdominal Aortic Aneurysm Zi Ye, 1 MD, Erin Austin, 1,2 PhD, Daniel J Schaid, 2 PhD, Iftikhar J. Kullo, 1 MD Affiliations: 1 Division of Cardiovascular Diseases and

More information

Sponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational.

Sponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational. Clinical Trial Results Database Page 1 Sponsor Novartis Generic Drug Name Vildagliptin Therapeutic Area of Trial Type 2 diabetes Approved Indication Investigational Study Number CLAF237A2386 Title A single-center,

More information

UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator(s)

UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator(s) UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator(s) Pilot QOF indicator: The percentage of patients 79

More information

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic

More information

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Connie N. Hess, MD, MHS, Stefan James, MD, PhD, Renato D. Lopes, MD, PhD, Daniel M. Wojdyla,

More information

Background & objectives

Background & objectives Indian J Med Res 138, October 2013, pp 531-535 Evaluation of the effectiveness of diagnostic & management decision by teleophthalmology using indigenous equipment in comparison with in-clinic assessment

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION European Medicines Agency Pre-Authorisation Evaluation of Medicines for Human Use London, 25 September 2008 Doc. Ref. EMEA/CHMP/EWP/311890/2007 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE

More information

Social inequalities in all cause and cause specific mortality in a country of the African region

Social inequalities in all cause and cause specific mortality in a country of the African region Social inequalities in all cause and cause specific mortality in a country of the African region Silvia STRINGHINI 1, Valentin Rousson 1, Bharathi Viswanathan 2, Jude Gedeon 2, Fred Paccaud 1, Pascal Bovet

More information

Risk Factors for Fire Fighter Cardiovascular Disease

Risk Factors for Fire Fighter Cardiovascular Disease Risk Factors for Fire Fighter Cardiovascular Disease EXECUTIVE SUMMARY Prepared by: Jefferey L. Burgess, MD, MS, MPH Mel and Enid Zuckerman College of Public Health The University of Arizona The Fire Protection

More information

IBADAN STUDY OF AGEING (ISA): RATIONALE AND METHODS. Oye Gureje Professor of Psychiatry University of Ibadan Nigeria

IBADAN STUDY OF AGEING (ISA): RATIONALE AND METHODS. Oye Gureje Professor of Psychiatry University of Ibadan Nigeria IBADAN STUDY OF AGEING (ISA): RATIONALE AND METHODS Oye Gureje Professor of Psychiatry University of Ibadan Nigeria Introduction The Ibadan Study of Ageing consists of two components: Baseline cross sectional

More information

NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN)

NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN) NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia Produced by: National Cardiovascular Intelligence Network (NCVIN) Date: August 2015 About Public Health England Public Health England

More information

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What

More information

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf

More information

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 New Treatments for Stroke Prevention in Atrial Fibrillation John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 Classification Paroxysmal atrial fibrillation (AF) Last < 7

More information

PRACTICE PROBLEMS FOR BIOSTATISTICS

PRACTICE PROBLEMS FOR BIOSTATISTICS PRACTICE PROBLEMS FOR BIOSTATISTICS BIOSTATISTICS DESCRIBING DATA, THE NORMAL DISTRIBUTION 1. The duration of time from first exposure to HIV infection to AIDS diagnosis is called the incubation period.

More information

The Big Data mining to improve medical diagnostics quality

The Big Data mining to improve medical diagnostics quality The Big Data mining to improve medical diagnostics quality Ilyasova N.Yu., Kupriyanov A.V. Samara State Aerospace University, Image Processing Systems Institute, Russian Academy of Sciences Abstract. The

More information

Rheumatoid Factor is a Strong Risk Factor for Coronary Artery Disease in Men with Metabolic Syndrome

Rheumatoid Factor is a Strong Risk Factor for Coronary Artery Disease in Men with Metabolic Syndrome Original Article RF is a Risk Factor for CAD in MS Men Acta Cardiol Sin 2010;26:89 93 Coronary Heart Disease Rheumatoid Factor is a Strong Risk Factor for Coronary Artery Disease in Men with Metabolic

More information

Effects of Cholesterol and Inflammation-Sensitive Plasma Proteins on Incidence of Myocardial Infarction and Stroke in Men

Effects of Cholesterol and Inflammation-Sensitive Plasma Proteins on Incidence of Myocardial Infarction and Stroke in Men Effects of Cholesterol and Inflammation-Sensitive Plasma Proteins on Incidence of Myocardial Infarction and Stroke in Men G. Engström, MD, PhD; P. Lind, MD; B. Hedblad, MD, PhD; L. Stavenow, MD, PhD; L.

More information

Multiple comorbidities: additive and predictive of cardiovascular risk. Peter M. Nilsson Lund University University Hospital Malmö, Sweden

Multiple comorbidities: additive and predictive of cardiovascular risk. Peter M. Nilsson Lund University University Hospital Malmö, Sweden Multiple comorbidities: additive and predictive of cardiovascular risk Peter M. Nilsson Lund University University Hospital Malmö, Sweden Clinical outcomes: major complications of CVD Heart Attack/ACS

More information

Cardiovascular Endpoints

Cardiovascular Endpoints The Malmö Diet and Cancer Study Department of Clinical Sciences Skåne University Hospital, Malmö Lund University The Malmö Diet and Cancer Study CV-cohort Cardiovascular Endpoints End of follow-up: 30

More information